Role of EndoFLIP in the Diagnostic Paradigm of Esophagogastric Junction Outflow Obstruction
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The aim of this project is to identify if EndoFLIP can categorize and change the diagnosis in
patients with EGJOO and if categorization with EndoFLIP can predict the response to treatment
with botulinum toxin at 12 weeks post procedure. Our hypothesis is that there will be a
larger difference in proportion of symptom resolution between the control and treatments
groups in the abnormal DI category than in the normal DI category.
Phase:
N/A
Details
Lead Sponsor:
University of Kansas Medical Center
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A